Metamizole Sodium Suppliers & Bulk Manufacturers

Available Forms: Tablets / Injection / Drop

Available Strengths: 500 mg, 500 mg/ml, 1 g/2 ml

Reference Brands: Novalgin (EU), Analgin, Nolotil,

Category: Analgesic

The salt Analgin is used for the treatment of Severe Pain Due To Cancer, Stomach Pain, Toothache, Headache and other conditions. Metamizole Sodium is available in Tablets / Injection / Drop and strengths such as 500 mg, 500 mg/ml, 1 g/2 ml. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Metamizole Sodium is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Metamizole Sodium can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description:

Analgin is used for the treatment, control, prevention, & improvement of the following diseases, conditions and symptoms: · Severe Pain Due To Cancer · Stomach Pain · Toothache · Headache

Metamizole sodium is a widely used non-opioid analgesic and antipyretic belonging to the pyrazolone class, known for its strong pain-relieving and fever-reducing properties. It is commonly prescribed for moderate to severe pain such as postoperative pain, colic, musculoskeletal pain, and high fever that does not respond to standard treatments like paracetamol or ibuprofen. In addition to its analgesic and antipyretic effects, metamizole sodium also exhibits mild antispasmodic activity, making it particularly effective in treating spasmodic conditions such as renal or biliary colic.

The drug works primarily by inhibiting prostaglandin synthesis and acting on the central nervous system to reduce pain perception and regulate body temperature. It is available in multiple dosage forms including tablets, injections, and oral solutions, allowing flexibility in both acute and chronic care settings. Although widely used in many countries across Europe, Latin America, and Asia, metamizole sodium is restricted or not approved in some regions such as the United States and the United Kingdom due to rare but serious risks like agranulocytosis. Despite this, it remains an important therapeutic option in regulated markets where its benefit-risk profile is considered acceptable under medical supervision.